Tuesday, 28 May 2019

The Melanoma Abstracts

As we make the last preparations for ASCO2019, a detailed look through the Abstracts gives a good idea of what is being studied in research and what are the "hot" areas for potential drug/therapy development and management. 

 The searchable Abstract lists are here . 

 I am hoping for some decent data on the anti PD1 PLUS combinations to prevent acquired resistance in the immunotherapies and also some strategies to improve the durability of Targeted Therapies. 
I also hope we have some better REAL WORLD data that will enrich what we have from the Clinical trials on optimal sequencing of therapies, identification and management of side effects and the most useful imaging and diagnostics to predict response and progression.  It is also also worth spending time learning from the other disease areas that use the same drug classes as us, to see what we can share from their experience.


at

2 comments:

  1. Bettina29 May 2019 at 04:14

    Who benefits from adjuvant Dab/ Tram therapy? EVERYONE.
    https://meetinglibrary.asco.org/record/174893/abstract

    ReplyDelete
  2. Bettina29 May 2019 at 04:32

    Brain mets are different from skin primaries with some interesting findings to think through.
    https://meetinglibrary.asco.org/record/174859/abstract

    ReplyDelete

Subscribe to: Post Comments (Atom)

Uveal Melanoma at ASCO 2019

What Is Available for the Treatment of Uveal/Mucosal Melanoma? Presented Sunday, June 2, 2019 https://meetinglibrary.asco.org/record/...

  • It's time again!
    We have started preparing for  ASCO  in Chicago! ASCO is the world's largest oncology congress and one of the conferences where Melan...
  • Melanoma- the big issues
    also- the MPNE conference hack ;-) Before any conference we attend,  we make a list of the most relevant topic screen the program for ...
  • The Melanoma Abstracts
    As we make the last preparations for ASCO2019, a detailed look through the Abstracts gives a good idea of what is being studied in research ...